COLLEGEVILLE PA – A European medicine agency has issued a positive opinion about a new vaccine developed by Collegeville PA-based Wyeth Pharmaceuticals that it hopes will prevent invasive pneumococcal disease, pneumonia, and middle ear infections in children age 6 weeks to 5 years old, the company said Friday (Sept. 25, 2009) in a press release.

The vaccine, called Prevenar 13, won a recommendation from the agency’s Committee for Medicinal Products for Human Use, Wyeth said. The committee action moves Wyeth a step close to selling the vaccine in European countries to protect infants and young children there from the targeted illnesses.

Overall, Wyeth said it is seeking approval for the vaccine in more than 50 countries spanning six continents.

See our galleries for photos that appear in The Post.
Got news for us? E-mail The Post.